Evidence map›Paper›PMID 42821518›Full record

ArticleThe American journal of case reports2026

Resistant Hypertension Secondary to Renal Arteriovenous Malformation: A Case of Cure After Nephrectomy.

Alexis Garza, Maximo Alvarez, Paul Kim, David Alonzo

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alexis GarzaUrology Institute, Doctors Hospital at Renaissance, Edinburg, TX, USA.
Maximo AlvarezUniversity of Texas - Rio Grande Valley School of Medicine, Edinburg, TX, USA.ORCID 0009-0009-8490-7868
Paul KimUniversity of Texas - Rio Grande Valley School of Medicine, Edinburg, TX, USA.ORCID 0009-0003-1872-0356
David AlonzoUrology Institute, Doctors Hospital at Renaissance, Edinburg, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Evaluation of multidrug-resistant hypertension in young adults requires consideration of uncommon secondary etiologies, including renovascular disease and congenital renal vascular anomalies. Renal arteriovenous malformations (rAVMs) represent a rare cause of secondary hypertension, accounting for less than 0.1% of renal vascular abnormalities. They most commonly present with hematuria, flank pain, or, in high-flow lesions, high output cardiac failure. Hypertension as the principal manifestation is uncommon. CASE REPORT We describe a 33-year-old woman with longstanding uncontrolled hypertension requiring 5 antihypertensive agents who presented for evaluation of refractory blood pressure control. Initial duplex ultrasound and angiography identified a large complex left renal lesion associated with dysmorphic parenchyma and aberrant arterial and venous architecture without a history of trauma, intervention, or prior renal surgery, consistent with a congenital vascular malformation. Diagnostic computed tomography angiography demonstrated a 6.5×6.5×5.5 cm arteriovenous malformation. Given the lesion's size and vascular complexity, endovascular embolization was deemed not technically feasible. The patient subsequently underwent elective simple nephrectomy without intraoperative complication. Histopathology confirmed a congenital high-flow rAVM with extensive parenchymal distortion. Postoperatively, the patient exhibited marked improvement in blood pressure control, eliminating the need for antihypertensive medication. CONCLUSIONS This case illustrates an uncommon presentation of severe drug-resistant hypertension in a young patient likely attributed to a large congenital rAVM. Congenital renal vascular malformations should be considered in the differential diagnosis of refractory hypertension. Surgical intervention remains an important therapeutic option when endovascular treatment is contraindicated or considered unlikely to preserve functional renal parenchyma.

Indexed as

Arteriovenous MalformationsHypertensionNephrectomyRenal ArteryRenal VeinsAdultAntihypertensive AgentsFemaleHumansAntihypertensive Agents

Identifiers

PMID42821518
PMCPMC13648107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.